BREAKING
CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 44 minutes ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 13 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 16 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 18 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 22 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 24 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 1 day ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 44 minutes ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 13 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 16 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 18 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 22 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 24 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 1 day ago
ADVERTISEMENT
Market News

Earnings Summary: Highlights of Waters Corporation’s (WAT) Q2 2025 results

Waters Corporation (NYSE: WAT), a provider of analytical instruments and software, reported financial results for the second quarter of fiscal 2025. Second-quarter sales increased 9% YoY to $771 million, exceeding the guidance range; in constant currency, sales grew 8% On a per-share basis, June quarter earnings rose to $2.47 from $2.40 per share in the […]

$WAT August 4, 2025 1 min read

Waters Corporation (NYSE: WAT), a provider of analytical instruments and software, reported financial results for the second quarter of fiscal 2025.

  • Second-quarter sales increased 9% YoY to $771 million, exceeding the guidance range; in constant currency, sales grew 8%
  • On a per-share basis, June quarter earnings rose to $2.47 from $2.40 per share in the prior-year quarter
  • Excluding special items, adjusted earnings per share grew 12% to $2.95 from $2.63 for the second quarter of 2024.
  • Net income was $147.1 million in Q2, compared to $142.7 million in Q2 2024
  • The Instruments division grew mid-single-digits in constant currency, with continued strength in instrument replacement
  • Recurring revenue rose 11% in constant currency in Q2, with a 9% Service growth and double-digit Chemistry growth
  • The management raised its full-year 2025 constant currency sales growth guidance to 5.5-7.5%
  • It also raised the full-year adjusted earnings per share guidance to $12.95 to $13.05
ADVERTISEMENT